Meanwhile, calponin, SMMHC, and P63 also showed weak and variable staining or were absent in these ductal carcinoma in situ lesions (Table 2), and there were no significant differences between DOG1 and the other three markers (P > 0.05). This evidence concerns the gene ANO1 and ductal breast carcinoma in situ.